Navigation Links
Shire plc: Continued Strong Product Sales Performance in Q3: On Track to Deliver Significant 2011 Earnings Growth
Date:10/28/2011

ncluded the up-front payment to Acceleron and the intangible asset impairment charges for DAYTRANA. Taken together, these costs increased the US GAAP tax rate in Q3 2010 as they were either incurred in territories with tax rates lower than Shire's effective rate or in territories where the establishment of valuation allowances precluded the recognition of any tax benefit. Were the impact of these items excluded the effective tax rate in Q3 2010 would have been 24%.

FINANCIAL INFORMATION

TABLE OF CONTENTS

Page Unaudited US GAAP Consolidated Balance Sheets 11 Unaudited US GAAP Consolidated Statements of Income 12 Unaudited US GAAP Consolidated Statements of Cash Flows 14 Selected Notes to the Unaudited US GAAP Financial Statements (1) Earnings per share 16 (2) Analysis of revenues 17 Non GAAP reconciliation 19

Unaudited US GAAP financial position as of September 30, 2011
Consolidated Balance Sheets

September 30, December 31, 2011 2010 $M $M ASSETS Current assets: Cash and cash equivalents 276.4 550.6 Restricted cash 21.0 26.8 Accounts receivable, net 844.7 692.5 Inventories 325.9 260.0 Deferred tax asset 179.0 182.0 Prepaid expenses and other current assets 159.3 168.4 Total current assets 1,806.3 1,880.3 Non-current assets: Investments 30.1 101.6 Property, plant and equipment, net 918.8 853.4 Goodwill 596.2 402.5 Other intangible assets, net 2,561.7 1,978.9 Deferred tax asset 109.5 110.4 Other non-current assets 43.0 60.5 Total assets 6,065.6 5,387.6 LIABILITIES AND EQUITY Current liabilities: Accounts payable and accrued expenses 1,312.7 1,239.3 Convertible bonds 1,100.0 - Deferred tax liability 4.3 4.4 Other current liabilities 56.0 49.6 Total current liabilities 2,473.0 1,293.3 Non-current liabilities: Convertible bonds - 1,100.0 Deferred tax liability 540.4 352.1 Other non-current liabilities 97.5 190.8 Total liabilities 3,110.9 2,936.2 Equity: Common stock of 5p par va
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Related biology technology :

1. NHS Northamptonshire Chief Executive John Parkes Accepts Visiting Professorship
2. FDA Approves Shires FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE)
3. Shires Quarterly Revenues Grow by 25% to $1 Billion for the First Time
4. Shire Files Lawsuits Against Watson and Roxane for Infringement of VYVANSE(R) (lisdexamfetamine dimesylate) Patents
5. Shire Presents Data at ACMG for Fabry and Gaucher Patients Who Switched to Replagal® (agalsidase alfa) and VPRIV® (velaglucerase alfa for injection)
6. Shire Reports Positive Signal Finding Study of Investigative Use of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules as Adjunctive Treatment in Major Depressive Disorder
7. Shire plc: Continued Excellent Performance in Q3, Full Year Earnings Expectations Increased, New Value in Pipeline Emerging
8. Shire Announces Results of the Tender Offer for Movetis NV and Commencement of Squeeze-Out Tender Period
9. Reportlinker Adds Shire plc: PharmaVitae Profile
10. Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
11. Shire plc - Statement re ProAmatine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Switzerland (PRWEB) , ... August 27, 2015 , ... ... on customers’ weighing needs and expertly narrows down the product choices to a ... selection criteria pares down the list to models that fit best with the ...
(Date:8/26/2015)... /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended June 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... our Oral Amp B program, rapidly advancing towards ... Andrew Rae , President & CEO of iCo ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... , August 26, 2015 After ... against Europlasma NV relating to P2i United States ... resolved their dispute in the United States ... on the part of either party. As a result of ... District of California dismissed the case ...
Breaking Biology Technology:METTLER TOLEDO Updates Online Scale Selection Tool 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 2iCo Therapeutics Announces Second Quarter 2015 Financial Results 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3P2i Settles United States Litigation 2
... BERLIN, July 13 The new ... appearance. An initiative recently,launched by Germany Trade & ... namely industrial biotechnology clusters and,chemical parks, in addition ... Germany,s biotechnology sector by creating new business,opportunities across ...
... Italy, July 13 Health Robotics today announced,that ... channel strategies,with direct investments in local infrastructure at ... distributors have been negatively affected by a,number of ... distributor,s,litigation with investors, and some financial difficulties supporting ...
... NATICK, Mass., July 13 Boston Scientific Corporation ... its LATITUDE(R) Patient Management system. The LATITUDE system remotely ... both the device and a patient,s heart health status. ... visits and send relevant data directly to a patient,s physician. ...
Cached Biology Technology:German Alliance for Industrial Biotechnology Debuts in Montreal 2Health Robotics Expands and Diversifies Global Channel Strategies With Joint-Ventures & Direct Operations 2Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 2Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 3Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System 4
(Date:8/24/2015)... South Africa , August 24, 2015 ... Germany ,s largest biometrics manufacturer DERMALOG and its ... with the "2015 African Biometrics Company of the Year Award". ... Nigeria .   -Cross reference: ... http://www.presseportal.de/nr/8896 - On Thursday evening, in ...
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/17/2015)... OXFORD, Conn. , Aug. 17, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces its new sales campaign for Q4 2015. The ... winning marketing team consisting of Amplitude Marketing Group ( ... Amplitude Marketing Group is a leader in retail driven ...
Breaking Biology News(10 mins):Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3
... for this press release has been lifted at the request ... alligators dive, surface or roll sideways, even though they lack ... silently by using their diaphragm, pelvic, abdominal and rib muscles ... tail when they dive, toward the head when they surface ...
... Peter Glynn, a professor at the University of Miamis ... selected to receive the 2007-2008 Provosts Award for Scholarly ... and provides the recipient with a cash award toward ... Glynn, who received the award when it was first ...
... filters that help remove and transform pollutants that drain ... Scientists know this as a result of many hours ... least very wet -- monitoring streams nationwide. Nitrogen ... potential for eutrophication the excessive growth of algae ...
Cached Biology News:How alligators rock and roll 2How alligators rock and roll 3How alligators rock and roll 4How alligators rock and roll 5UM coral scientist Peter Glynn wins award for scholarly activity 2Streams natural filters, if not overloaded 2
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Image Acquisition and documentation system for fluorescent and non-fluorescent gels, membranes, blots, film, plates and assays...
PC based system for superior chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Biology Products: